Difference between revisions of "Gardasil"
(added cancer link) |
|||
| Line 1: | Line 1: | ||
| − | The HPV vaccine protects against some strains of the human papillomavirus (HPV), which are sexually transmitted diseases. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls). | + | The HPV vaccine protects against some strains of the human papillomavirus (HPV), which are sexually transmitted diseases. HPV is the primary cause of cervical cancer and may also play a role in the development of other types of cancer [http://www.cancer.gov/cancertopics/factsheet/Risk/HPV |
| + | ]. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls). | ||
Merck manufactures the HPV vaccine and sells it for $360 ($120 per shot in a three-shot series). Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref> | Merck manufactures the HPV vaccine and sells it for $360 ($120 per shot in a three-shot series). Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref> | ||
Revision as of 22:51, March 8, 2007
The HPV vaccine protects against some strains of the human papillomavirus (HPV), which are sexually transmitted diseases. HPV is the primary cause of cervical cancer and may also play a role in the development of other types of cancer [http://www.cancer.gov/cancertopics/factsheet/Risk/HPV ]. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated antibody levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls).
Merck manufactures the HPV vaccine and sells it for $360 ($120 per shot in a three-shot series). Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.[1]
A list of pending statutes in NJ for the HPV vaccine is here.
Sources: